BOTHELL, Wash., Jan. 17, 2023 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced…
BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences
Technology and Entertainment Magazine
Contact us
renewsindustry@gmail.com
+92 318 3083960